These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3107 related articles for article (PubMed ID: 15963817)

  • 1. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
    Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
    Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
    Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.
    Lai R; Juco J; Lee SF; Nahirniak S; Etches WS
    Am J Clin Pathol; 2000 Jun; 113(6):823-30. PubMed ID: 10874883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
    Rütgen BC; Hammer SE; Gerner W; Christian M; de Arespacochaga AG; Willmann M; Kleiter M; Schwendenwein I; Saalmüller A
    Leuk Res; 2010 Jul; 34(7):932-8. PubMed ID: 20153049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GeneScanning analysis of Ig/TCR gene rearrangements to detect clonality in canine lymphomas.
    Gentilini F; Calzolari C; Turba ME; Bettini G; Famigli-Bergamini P
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):47-56. PubMed ID: 18963006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
    Milner RJ; Pearson J; Nesbit JW; Close P
    Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene rearrangements in T-cell lymphoblastic lymphoma.
    Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
    J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marker discrepancy as a diagnostic criterion for lymphoid neoplasms.
    Sun T; Ngu M; Henshall J; Cuomo J; Eisenberg A; Benn P; Allen SL
    Diagn Clin Immunol; 1988; 5(6):393-9. PubMed ID: 3265362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma.
    Comazzi S; Gelain ME
    Vet J; 2011 May; 188(2):149-55. PubMed ID: 20413335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 156.